Rising Preference For Minimally Invasive Procedures Driving Market Growth: A Key Driver Powering Embolotherapy Market Growth In 2025

We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.

What Is the Current Embolotherapy Market Size and Its Estimated Growth Rate?
The size of the embolotherapy market has seen robust growth over the past few years. The industry, which was valued at $4.44 billion in 2024, is expected to rise to $4.86 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 9.3%. This noteworthy growth during the historical period is largely due to the rising need for embolotherapy treatments, an increase in cancer cases, a surge in peripheral vascular diseases, elevated healthcare spending, and greater research investments.

The market size of embolotherapy is predicted to witness robust expansion in the forthcoming years. It is projected to escalate to $6.83 billion in 2029, with a compound annual growth rate (CAGR) of 8.9%. The ascent in the predicted period can be credited to increased disposable income, growing prevalence of chronic ailments, rising adoption in the field of reproductive health, heightened number of cheoembolization procedures, and an escalating occurrence of liver cancer. Prominent trends observed in the forecast period encompass advanced technologies, digital and analog devices, implantable cardiac monitor, techniques related to embolotherapy, and strategic collaborations.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21181

How Are Emerging Segments Shaping the Embolotherapy Market Landscape?
The embolotherapy market covered in this report is segmented -

1) By Product: Embolization Coil, Embolic Agents, Detachable Balloons, Embolic Plug Systems, Support Devices
2) By Application: Oncology, Peripheral Vascular Diseases, Urology and Nephrology, Neurology, Gastrointestinal (GIT) Disorders
3) By Procedure: Transcatheter Arterial Embolization (TAE), Transcatheter Arterial Radioembolization (TARE) Or Selective Internal Radiation Therapy (SIRT), Transarterial Chemoembolization (TACE)
4) By End User: Ambulatory Surgical Centre, Hospitals And Clinics, Other End Users

Subsegments:
1) By Embolization Coil: Bare Coils, Coated Coils, Micro Coils
2) By Embolic Agents: Liquid Embolic Agents, Particulate Embolic Agents, Gelatin Sponge, Polyvinyl Alcohol (PVA) Particles
3) By Detachable Balloons: Single-Use Balloons, Multi-Use Balloons
4) By Embolic Plug Systems: Plug Kits, Distal Occlusion Systems
5) By Support Devices: Guidewires, Catheters, Sheath Introducers

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21181&type=smp

Which Growth Factors Are Influencing Embolotherapy Market Expansion?
The growing inclination towards minimally invasive procedures is set to fuel the expansion of the embolotherapy market. Minimally invasive procedures include cosmetic treatments that necessitate minimal to no surgical involvement, usually accompanied by a shorter healing time and decreased risks. Factors such as quicker recovery times, less pain, smaller scars, reduced chances of complications, and technological progress are augmenting this growing inclination. Embolotherapy compliments these procedures by specifically obstructing blood flow to chosen vessels, minimizing bleeding, addressing tumors, and handling vascular irregularities with an enhanced precision and fewer complications. For example, in September 2023, the American Society of Plastic Surgeons, a non-profit organization from the US, reported a 7% increase in cosmetic minimally invasive procedures in 2023, tallying up to 25,442,640 from 23,672,269 in 2022. Hence, this growing penchant for minimally invasive procedures is contributing to the development of the embolotherapy market.

Who Are the Dominant Players Across Different Embolotherapy Market Segments?
Major companies operating in the embolotherapy market are Boston Scientific Corporation, Terumo Medical Corporation , Medtronic PLC, Johnson And Johnson, Stryker Corporation, Sirtex Medical, Abbott Laboratories, Acandis GmbH, Balt Group LLC, Penumbra Inc, Merit Medical Systems, Kaneka Corporation, Meril Life Sciences Pvt. Ltd., Shape Memory Medical Inc, Guerbet, IMBiotechnologies Ltd, Cardiva , Rapid Medical, Emboline Inc, Microport Scientific, Inari Medical, Instylla Inc, Embolx Inc, GE Healthcare, Lepu Medical Technology Co Ltd, WEGO HEALTHCARE (SHENZHEN) CO., LTD, Achieva Medical Inc, Varian Medical Syatems Inc

What Are the Latest Developing Trends in the Embolotherapy Market?
Leading firms contributing to the embolotherapy market are prioritizing the development of modern products such as absorbable embolic systems. These innovative products aim to improve patient experiences and broaden therapy options. Absorbable embolic systems encompass bioresorbable materials utilized in embolization practices to obstruct blood supply to specific tissues like tumors or aneurysms, and these systems decompose over time within the human body. For example, in January 2025, Instylla Inc., a medical equipment manufacturer based in the U.S., obtained 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Tembo embolic system. This is a bioresorbable embolization agent featuring irregularly shaped dry-gelatin particles with a size range of 85-255 μm. Its purpose is to embolize hypervascular tumors and block blood vessels in peripheral vasculature. As per Instylla, Tembo brings benefits such as convenient preparation, excellent visibility, and the capacity to densely load the treated vessels, thereby possibly enhancing existing permanent embolic solutions.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/embolotherapy-global-market-report

Which Geographic Regions Are Expected to Dominate the Embolotherapy Market in the Coming Years?
North America was the largest region in the embolotherapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the embolotherapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Embolotherapy Market?
2. What is the CAGR expected in the Embolotherapy Market?
3. What Are the Key Innovations Transforming the Embolotherapy Industry?
4. Which Region Is Leading the Embolotherapy Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.